BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38281745)

  • 21. Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration.
    In A; Stopa BM; Cuoco JA; Stump MS; Apfel LS; Rogers CM
    World Neurosurg; 2023 Nov; 179():118-126. PubMed ID: 37574195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
    Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
    Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.
    Satou A; Tabata T; Miyoshi H; Kohno K; Suzuki Y; Yamashita D; Shimada K; Kawasaki T; Sato Y; Yoshino T; Ohshima K; Takahara T; Tsuzuki T; Nakamura S
    Mod Pathol; 2019 Jul; 32(8):1135-1146. PubMed ID: 30952973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
    Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
    Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.
    Shiraiwa S; Kikuti YY; Carreras J; Kondo Y; Ohmachi K; Ogawa Y; Kawada H; Sato S; Gion Y; Sato Y; Nakamura N; Ando K
    Am J Surg Pathol; 2022 Aug; 46(8):1017-1024. PubMed ID: 35848760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
    Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
    Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
    Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
    J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features.
    Satou A; Banno S; Kohno K; Takahara T; Takahashi E; Nobata H; Iwagaitsu S; Watanabe D; Hanamura I; Takami A; Ito Y; Nakamura S; Tsuzuki T
    Pathology; 2021 Aug; 53(5):595-601. PubMed ID: 33618861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study.
    Torii A; Oki M; Iida H; Yamada A; Kogure Y; Kitagawa C; Saka H
    Pulm Pharmacol Ther; 2024 Jun; 85():102297. PubMed ID: 38467341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
    Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
    World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.
    Shiraiwa S; Kikuti YY; Carreras J; Hara R; Aoyama Y; Ogiya D; Suzuki R; Toyosaki M; Ohmachi K; Ogawa Y; Kawada H; Sato S; Nakamura N; Ando K
    J Clin Exp Hematop; 2020 Dec; 60(4):159-168. PubMed ID: 33148934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
    Toyonaga H; Fukushima M; Shimeno N; Inokuma T
    BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
    Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
    Omameuda T; Miyato H; Sata N; Lefor AK
    Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Central Nervous System Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis: Case Report and Review of Literature.
    Uneda A; Hirashita K; Kanda T; Yunoki M; Yoshino K; Kurozumi K; Date I
    NMC Case Rep J; 2020 Jul; 7(3):121-127. PubMed ID: 32695560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
    He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
    Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Treatment of Intracranial Methotrexate-associated Lymphoproliferative Disorder without Epstein-Barr Virus Infection Using Rituximab, Methotrexate, Procarbazine, and Vincristine: A Case Report.
    Mizushima M; Ishi Y; Ikeda H; Echizenya I; Otsuka T; Mitsuhashi T; Yamaguchi S; Fujimura M
    NMC Case Rep J; 2022; 9():237-242. PubMed ID: 36061907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.